Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

52.18
+0.69001.34%
Volume:420.75K
Turnover:21.30M
Market Cap:1.49B
PE:133.79
High:52.20
Open:50.18
Low:49.67
Close:51.49
52wk High:66.37
52wk Low:14.27
Shares:28.58M
Float Shares:22.30M
Volume Ratio:1.13
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:32.02
PE(LYR):-305.16

Loading ...

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate Asn-001

THOMSON REUTERS
·
Aug 05

Eton Pharmaceuticals Names Danka Radosavljevic Chief Operating Officer

Reuters
·
Aug 04

Eton Pharma to Report Q2 2026 Results, Host Conference Call and Webcast

Reuters
·
Aug 03

Is Eton Pharmaceuticals (ETON) Quietly Reframing Its Orphan-Drug Strategy With KHINDIVI’s Label Expansion Bid?

Simply Wall St.
·
Jul 30

Eton Pharma Submits FDA Supplement to Expand Khindivi Label to Younger Pediatric Patients

Reuters
·
Jul 29

Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of Khindivi® (Hydrocortisone) Oral Solution

THOMSON REUTERS
·
Jul 29

Eton Pharmaceuticals is Maintained at Buy by Craig-Hallum

Dow Jones
·
Jul 29

Eton Pharmaceuticals price target raised to $62 from $40 at Craig-Hallum

TIPRANKS
·
Jul 28

Eton Pharmaceuticals (ETON) Stock Looks Overvalued Even After Recent Wins

Simply Wall St.
·
Jul 18

Eton Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17

Opaleye Management Disposes of 28,315 Eton Pharma Shares Worth $1.06 Million

Reuters
·
Jul 17

Eton Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Opaleye Management Sells 126,685 Eton Pharma Shares for $4.8 Million

Reuters
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jun 27

Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 million

Reuters
·
Jun 18

Eton Pharmaceuticals shareholders elect two directors at annual meeting

Reuters
·
Jun 10

Eton Pharma CFO Judith Matthews files initial beneficial ownership statement

Reuters
·
Jun 02

Eton Pharma CEO Sean Brynjelsen sells common shares worth $3.87 million

Reuters
·
May 30

Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million

Reuters
·
May 28